Table 1.
Patient Groups | P-ANCA Serum Titers (No Positive) | ||||||
---|---|---|---|---|---|---|---|
≥1:640 | 1:320 | 1:160 | 1:80 | 1:40 | 1:20 | ||
Vasculitides | MPA (n = 18) | 9 | 5 | 1 | 1 | 1 | 1 |
BD (n = 2) | 1 | 1 | 0 | 0 | 0 | 0 | |
Aortitis (n = 1) | 1 | 0 | 0 | 0 | 0 | 0 | |
HSP (n = 2) | 0 | 0 | 1 | 1 | 0 | 0 | |
CV (n = 1) | 0 | 1 | 0 | 0 | 0 | 0 | |
SLE (n = 28) | 9 | 6 | 3 | 7 | 23 | 0 | |
APS (n = 5) | 1 | 1 | 1 | 1 | 0 | 1 | |
SS (n = 7) | 5 | 0 | 0 | 0 | 0 | 2 | |
RA (n = 3) | 2 | 0 | 0 | 1 | 0 | 0 | |
SSCL (n = 1) | 0 | 1 | 0 | 0 | 0 | 0 | |
Sarcoidosis | (n = 1) | 0 | 0 | 1 | 0 | 0 | 0 |
Hashimoto | (n = 13) | 2 | 1 | 4 | 2 | 1 | 3 |
P-ANCA: perinuclear antineutrophil cytoplasmic antibodies, MPA: microscopic polyangiitis, BD: Behcet’s disease, HSP: Henoch–Schonlein purpura, CV: cryoglobulinemic vasculitis, SLE: systemic lupus erythematosus, APS: antiphospholipid syndrome, SS: Sjögren’s syndrome, RA: rheumatoid arthritis, SSCL: systemic sclerosis.